Fig1 skin antigens

Anti-laminin β4 – a new autoantibody marker in pemphigoid disease

Laminin β4 (lamβ4) has been identified as a novel target antigen in anti-p200 pemphigoid, a rare autoimmune disease manifesting with subepidermal blisters. Anti-lamβ4 antibodies bind to the region of the dermal–epidermal junction and demonstrate pathogenic effects. A recombinant-cell indirect immunofluorescence assay has been developed for specific detection of anti-lamβ4 antibodies.

AdobeStock 199128755

Identification of putative breath biomarkers for detection of lymphoma

Volatile organic compounds (VOCs) are released from our bodies in our breath, sweat, blood and urine as a result of metabolic activity and so provide a window on our metabolic and physiological status. These VOCs change in response to disease, providing the potential for disease-specific VOCs in the breath to be used as non-invasive biomarkers […]

Scherm­afbeelding 2025 11 07 om 09.23.35

ACD/Labs expands Katalyst D2D software capabilities for pharmaceutical development

ACD/Labs has released version 25.4 of Katalyst D2D, extending the industry-leading workflow digitalisation software beyond its original high throughput experimentation applications to support process scale-up and material characterisation in pharmaceutical development. The enhanced platform enables pharmaceutical project teams to accelerate the design-make-test-analyse cycle from discovery through to clinical trials.

AdobeStock 1628206991 Omgezet e1762439956239

Point-of-care test for detection of the FKBP12 biomarker at single-molecule level

FK506 (tacrolimus) binding protein 12 (FKBP12) is involved in fundamental cellular processes as well as immunosuppression, neurodegenerative diseases and cancer. Hence, the ability to quickly and easily determine its levels is desirable. CLI caught up with Dr Pitruzzella, Dr Caminati and Prof. Cennamo to find out more about the point-of-care test that they have developed […]

Wexis Atomizer

Wexis introduces Atomizer to enhance section adhesion, precision

Wexis has unveiled the Atomizer, a breakthrough in microtomy workflow designed to enhance section adhesion, precision, and efficiency.

Scherm­afbeelding 2025 11 07 om 12.39.04

OHAUS introduces IVD-compliant centrifuge range with low-impact refrigerant

OHAUS Corporation has introduced a new series of centrifuges designed for in vitro diagnostic applications, featuring natural refrigerant R290 with substantially reduced environmental impact compared to conventional cooling systems.

Azenta

Azenta Life Sciences expands cap carrier portfolio for enhanced sample tube processing

Azenta Life Sciences has launched 24- and 48-format cap carriers to complement its existing 96-format solution, providing clinical laboratories with flexible, scalable options for automated sample tube management across diverse applications.

Proimmune ProVE SL Monomer

ProImmune unveils self-loading MHC Class I monomers for enhanced T cell research

ProImmune Ltd has introduced ProVE SL Self-Loading MHC Class I Monomers, a new platform designed to provide researchers with greater flexibility in antigen-specific CD8+ T cell detection studies.

Alithea Genomics

Alithea Genomics launches extraction-free RNA sequencing kit for 3D spheroid drug screening

Alithea Genomics has introduced MERCURIUS® Spheroid DRUG-seq, an RNA sequencing library preparation kit designed to streamline transcriptomic analysis of three-dimensional spheroid models without requiring conventional RNA extraction steps.

trimero

Trimero’s κλoneus kits offer alternative approach for Bence-Jones proteinuria detection

κλoneus Free Light Chain (FLC) kits from Spanish in vitro diagnostics manufacturer Trimero Diagnostics SL offer clinical laboratories an alternative approach for determining Bence-Jones proteinuria based on International Federation of Clinical Chemistry (IFCC) guidelines.